YOLFTbeta
Kuros Biosciences AG

Kuros Biosciences AG

KURN · SW · Healthcare / Medical Devices

19.47CHF-0.23 (-1.17%)

Price History

Full chart

Market Stats

Previous Close19.70
Open19.70
Day Range19.19 – 19.70
52-Week Range16.46 – 34.20
Volume101.82K
Market Cap739.11M
P/E (TTM)103.50
Forward P/E0.00
EPS0.18
Dividend Yield0.00%
Beta0.74
50-Day Avg20.13
200-Day Avg22.54

About

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Christopher T. Fair B.B.A.
  • Employees213
  • HeadquartersWagistrasse 25, Schlieren, Switzerland, 8952, Switzerland
  • Websitehttps://kurosbio.com

Leadership

  • Mr. Christopher T. Fair B.B.A.CEO & Director · b. 1970
  • Mr. Daniel GeigerChief Financial Officer · b. 1971
  • Dr. Joost D. de Bruijn B.Sc. Ph.D., Ph.D.President of Innovation and Strategy & Executive Director · b. 1966
  • Mr. Harry Thomas HallChief Operating Officer
  • Mr. G. Joseph RossSenior Vice President of Marketing & Business Development · b. 1968
  • Ms. Laura RosaSenior Vice President of Global Human Resources
  • Dr. Philippe Saudan Ph.D.Senior Vice President of Quality, Regulatory & Clinical · b. 1967
  • Mr. John GriffinChief Business Officer
  • Ms. Carly DummerSenior Director of Marketing
  • Dr. Virginia JamiesonConsultant · b. 1953

Financials

Income Statement

Currency: CHF2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.11M4.36M724.00K35.88M19.72M9.11M22.35M1.57M1.10M1.00M1.00M6.36M1.06M534.00K715.00K2.56M4.04M13.81M17.99M33.56M75.56M121.30M
Growth (%)-+5.98%-83.39%+4856.08%-45.03%-53.82%+145.38%-92.97%-29.98%-9.09%0.00%+535.50%-83.30%-49.67%+33.90%+258.18%+57.71%+242.04%+30.19%+86.61%+125.11%+60.54%
Cost of Revenue--11.20M17.40M-----12.95M10.10M563.00K7.91M3.31M3.42M2.64M2.37M3.75M7.22M9.63M13.52M16.51M
Gross Profit4.11M4.36M-10.48M18.48M19.72M9.11M22.35M1.57M1.10M-11.95M-9.10M5.79M-6.85M-2.77M-2.70M-79.00K1.67M10.07M10.77M23.94M62.03M104.79M
Gross Margin100.00%100.00%-1446.96%51.51%100.00%100.00%100.00%100.00%100.00%-1194.90%-910.10%91.14%-645.43%-518.91%-377.76%-3.08%41.37%72.86%59.87%71.31%82.10%86.39%
Operating Expense28.29M33.67M24.61M26.78M43.61M36.35M26.21M21.29M14.60M11.32M9.84M5.14M14.50M13.47M11.03M11.31M13.35M18.83M24.21M37.13M67.03M97.47M
Operating Income-24.18M-29.32M-35.09M-8.30M-23.88M-27.24M-3.86M-19.71M-13.49M-23.27M-18.94M654.00K-21.35M-16.24M-13.73M-11.39M-11.68M-8.77M-13.45M-13.19M-5.00M7.33M
Operating Margin-587.94%-672.72%-4846.82%-23.13%-121.09%-299.07%-17.29%-1254.87%-1226.82%-2326.60%-1893.70%10.29%-2011.88%-3041.76%-1919.86%-444.83%-289.16%-63.46%-74.76%-39.30%-6.61%6.04%
EBITDA-21.75M-26.75M-31.71M-3.27M-18.76M-17.84M4.77M-14.06M-6.30M-22.92M-18.84M-4.06M-19.31M-15.10M-11.74M-8.46M-8.58M-5.29M-8.84M-6.84M-561.00K10.13M
EBITDA Margin-529.06%-613.81%-4379.28%-9.12%-95.12%-195.82%21.33%-894.84%-572.73%-2292.10%-1884.00%-63.95%-1820.17%-2826.97%-1641.96%-330.26%-212.35%-38.30%-49.15%-20.37%-0.74%8.35%
Net Income-23.85M-28.48M-34.55M-6.88M-26.01M-24.83M-1.45M-18.78M-9.22M-30.83M-34.03M6.23M-19.74M-16.48M-11.69M-11.25M-11.52M-7.54M-14.60M-13.73M-3.72M2.12M
Net Income Margin-580.01%-653.51%-4772.38%-19.16%-131.87%-272.57%-6.51%-1195.35%-837.82%-3082.60%-3402.60%97.99%-1860.89%-3086.89%-1635.38%-439.36%-285.22%-54.59%-81.15%-40.90%-4.92%1.75%
R&D26.14M29.48M--39.49M32.97M22.21M16.69M10.89M20.45M17.47M1.08M7.91M4.47M6.88M6.48M4.00M4.99M5.19M2.03M6.98M8.86M
R&D as % of Total Revenue635.63%676.41%--200.25%362.01%99.40%1062.51%989.82%2044.90%1747.30%17.07%745.43%837.08%962.52%252.91%99.16%36.11%28.88%6.05%9.24%7.31%
Interest Expense0052.00K3.74M4.51M4.52M4.17M2.99M3.82M7.83M15.19M1.76M145.00K393.00K126.00K651.00K848.00K1.38M4.32M186.00K149.00K304.79K
Interest Expense % of Total Revenue0.00%0.00%7.18%10.42%22.87%49.58%18.66%190.52%347.18%782.50%1518.50%27.73%13.67%73.60%17.62%25.42%21.00%10.01%24.00%0.55%0.20%0.25%

Balance Sheet

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets88.37M82.39M57.41M123.56M110.75M68.70M54.07M30.81M30.39M40.50M17.63M3.26M43.77M86.08M85.82M87.85M94.36M91.34M82.95M71.46M84.54M107.21M
Total Liabilities8.19M8.38M11.51M69.13M78.89M60.46M47.48M42.49M20.36M36.27M43.85M2.59M5.45M12.94M9.34M10.00M9.76M14.36M14.09M14.75M25.79M40.28M
Total Equity80.17M74.01M45.90M54.43M31.86M8.24M6.59M-11.68M10.03M4.23M-26.22M669.00K38.32M73.14M76.48M77.86M84.60M76.98M68.86M56.71M58.75M66.93M
Cash21.03M11.47M9.15M43.04M40.32M20.97M33.78M24.54M28.59M39.85M16.93M2.09M12.37M16.67M18.33M20.80M28.39M28.62M24.07M14.21M17.46M15.66M
Total Debt--1.22M58.40M60.89M51.86M39.04M35.72M13.92M25.17M37.59M3.69M---2.39M2.34M8.93M1.91M2.14M1.79M3.94M
Net Debt-21.03M-11.47M-7.93M15.36M20.57M30.89M5.26M11.17M-14.67M-14.68M20.66M1.60M-12.37M-16.67M-18.33M-18.41M-26.05M-19.70M-22.15M-12.06M-15.67M-11.72M

Cash Flow

Currency: CHF2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-22.68M-27.08M-28.67M-4.40M-27.89M-15.25M-4.68M-8.81M-11.54M-19.17M-23.76M-2.51M-8.89M-10.68M-12.84M-10.85M-9.24M-5.45M-7.35M-8.84M3.14M-377.87K
Investing Cash Flow-26.63M-3.76M21.39M-33.02M26.54M4.17M29.12M3.95M4.02M125.00K571.00K1.81M1.81M-905.00K-652.00K-118.00K-220.00K-374.00K-400.00K-326.00K-1.11M-2.03M
Financing Cash Flow32.45M21.27M4.93M71.30M-1.63M-8.28M-11.26M-4.02M11.57M30.13M190.00K-12.31M3.46M15.98M15.02M13.13M17.08M6.08M3.22M-171.00K1.34M1.17M
Capital Expenditure2.48M2.19M1.78M926.00K468.00K37.00K30.00K184.00K24.00K92.00K20.00K50.00K50.00K1.57M662.00K118.00K220.00K374.00K400.00K326.00K1.11M2.03M
Free Cash Flow-25.16M-29.27M-30.46M-5.32M-28.36M-15.29M-4.71M-8.99M-11.56M-19.26M-23.78M-2.51M-8.94M-12.25M-13.50M-10.97M-9.46M-5.83M-7.75M-9.17M2.03M-2.40M
FCF to OCF110.94%108.08%106.21%121.06%101.68%100.24%100.64%102.09%100.21%100.48%100.08%100.00%100.56%114.73%105.16%101.09%102.38%106.86%105.44%103.69%64.59%636.05%

Earnings

Report DateDec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Feb 14, 2008Apr 24, 2008Jul 24, 2008Oct 23, 2008Feb 11, 2009Apr 22, 2009Jul 23, 2009Oct 22, 2009Feb 3, 2010Apr 22, 2010Jul 22, 2010Oct 28, 2010Feb 18, 2011Apr 29, 2011Jul 29, 2011Oct 20, 2011Feb 17, 2012Apr 20, 2012Jul 30, 2012Nov 6, 2012Feb 14, 2013Apr 25, 2013Aug 6, 2013Oct 31, 2013Feb 13, 2014May 2, 2014Sep 22, 2014Oct 27, 2014Feb 3, 2016Oct 4, 2016Mar 1, 2017Sep 26, 2017Feb 28, 2018May 4, 2018Sep 5, 2018Nov 1, 2018Apr 23, 2019Aug 20, 2019Oct 31, 2019Apr 22, 2020Aug 12, 2020Oct 29, 2020Mar 18, 2021Apr 22, 2021Aug 11, 2021Oct 28, 2021Apr 27, 2022Aug 9, 2022Oct 26, 2022Mar 15, 2023Apr 27, 2023Aug 23, 2023Oct 25, 2023Mar 13, 2024Apr 17, 2024Aug 7, 2024Oct 10, 2024Mar 12, 2025Apr 15, 2025Aug 14, 2025Oct 16, 2025Mar 3, 2027
EPS Estimate----------------------------------------0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00-
EPS Actual-65.36-72.88-90.08-97.86-112.63-122.13-64.08-108.92-112.50-117.47-119.21-110.71-75.14-180.00270.29-132.54-133.05-70.71-141.908.10-152.80-80.24-73.07-15.83-49.44180.85-77.85-86.13-68.89-61.23-78.99-34.3432.83-19.78-27.54-18.22-18.04-27.13-25.24-29.880.000.000.00-1.03-2.61-1.25-1.11-1.200.00-0.630.00-0.74-0.350.00-0.39-0.260.00-0.230.00-0.010.00-0.23-0.110.00-0.320.000.000.000.000.00-0.010.000.00-0.01-0.050.00-
Surprise-----------------------------------------------------------------------------
Timing--------------------------------------------After-hours-Pre-market-Pre-marketPre-market-After-hoursAfter-hours---------Pre-market-Pre-market-After-hours--After-hours----After-hours-Pre-market

Key Statistics & Ratios

Market Cap739.11M
Enterprise Value696.94M
Trailing P/E103.50
Forward P/E0.00
PEG Ratio0.00
Price / Sales4.23
Price / Book9.51
EPS0.18
Book Value1.75
Revenue (TTM)174.93M
Gross Profit (TTM)151.08M
EBITDA13.38M
Profit Margin5.13%
Operating Margin5.61%
Return on Equity10.73%
Return on Assets5.13%
Shares Outstanding39.67M
Shares Float30.55M
Beta0.74
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 8, 2020826:761
  • Nov 22, 201953:49
  • Dec 4, 201858:55
  • Jun 21, 2017720:701
  • Jun 23, 20161:100
  • Nov 6, 2013533:506
  • Apr 24, 2012165:151
  • Mar 17, 20043125:3001